Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar Announces Second Quarter 2006 Results Aug 03, 2006 Nektar Closes Its Bradford UK Site; Company Focusing on Development of Products Using its Drug Delivery Technology Jul 26, 2006 Nektar Announces Receipt of $17.6 Million Payment From Affymax, Inc. Under Agreement for Nektar Advanced PEGylation Technology; Cash Payment Resulting From Affymax and Takeda Signing Global Agreement for Hematide(TM) for the Treatment of Anemia Jul 24, 2006 Nektar Reports That Pfizer to Introduce Exubera in U.S. With a Comprehensive Education Program Jul 20, 2006 Advisory: Nektar Sets Announcement Date and Conference Call for the Second Quarter 2006 Jul 19, 2006 Nektar and University of Alabama in Huntsville Announce Agreement to Settle Litigation Jul 07, 2006 Nektar Reports Pfizer Announcement That New Studies Show More Than Half of Patients at Risk for or Suffering from Complications of Type 2 Diabetes Delay Insulin Injections -- Some More Than Four Years Jun 12, 2006 Nektar Reports Pfizer Announcement of New Exubera Data; New Data from Two Large Phase III Trials Reinforce Exubera's Long-Term Efficacy and Safety in Adults with Type 1 or Type 2 Diabetes Jun 10, 2006 Advisory: Nektar Therapeutics to Webcast its 2006 Annual Meeting of Stockholders May 23, 2006 FDA Grants Fast Track Designation to Nektar's Amphotericin B Inhalation Powder (ABIP) for Prevention of Pulmonary Fungal Infections in At-Risk Patients; First Inhaled Anti-Fungal Therapy Under Development for Immunosuppressed Patients May 22, 2006 Pagination First page « first Previous page ‹ previous … Page 48 Page 49 Page 50 Page 51 Page 52 Page 53 Current page 54 Page 55 Page 56 Next page next › Last page last »